The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation
Gwen S Scott, Rhonda B Kean, Tatiana Mikheeva, Marzena J Fabis, Jon G Mabley, Csaba Szabó, D Craig Hooper
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation'. Together they form a unique fingerprint.